Australia markets open in 1 hour 15 minutes

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2400+0.0600 (+5.08%)
At close: 04:00PM EST
1.2400 0.00 (0.00%)
After hours: 04:00PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
6,929
20,948
0
6
1,018
Cost of revenue
6,957
9,163
-
-
-
Gross profit
-28
11,785
-
-
-
Operating expenses
Research development
67,310
52,975
43,859
21,474
12,847
Selling general and administrative
19,084
16,180
13,418
12,354
9,993
Total operating expenses
86,394
69,155
57,277
33,828
22,840
Operating income or loss
-86,422
-57,370
-57,277
-33,822
-21,822
Total other income/expenses net
-149
568
-46
1,538
261
Income before tax
-86,511
-56,241
-55,178
-30,055
-21,561
Income from continuing operations
-86,511
-56,241
-55,178
-30,055
-21,561
Net income
-86,511
-56,241
-55,178
-30,055
-21,561
Net income available to common shareholders
-86,511
-56,241
-55,178
-30,055
-25,512
Basic EPS
-
-2.93
-4.60
-2.68
-7.45
Diluted EPS
-
-2.93
-4.60
-2.68
-7.45
Basic average shares
-
19,179
12,004
11,214
3,424
Diluted average shares
-
19,179
12,004
11,214
3,424
EBITDA
-
-57,232
-57,131
-33,673
-21,649